Navigation Links
Nortis Awarded $688K NIH Phase II SBIR Fast Track Grant to Develop Living Model of Human Blood-Brain Barrier
Date:8/18/2017

SEATTLE, Aug. 18, 2017 /PRNewswire/ -- Nortis today announced the awarding of a $688K National Institutes of Health (NIH) grant. The award will provide funding for the third year of a Small Business Innovation Research (SBIR)?Fast-track grant under award number R44NS095585 from the National Institute of Neurological Disorders and Stroke (NINDS).? 

Nortis ParVivo Chip used for 3D Organs-on-Chip Applications
Nortis ParVivo Chip used for 3D Organs-on-Chip Applications

The neurotherapeutics sector is among the largest and fastest growing markets in the pharmaceutical industry. Progress has been slow due to the lack of in-vitro assays that reliably predict outcomes in humans. The grant will allow Nortis to expand applications for its proprietary ParVivo™ system into the field of human blood-brain barrier (BBB), addressing the critically unmet need for more effective in-vitro testing systems that model human brain diseases such as Alzheimer's, multiple sclerosis, Parkinson's, stroke and cancer. 

"Understanding how drugs are transported across the blood-brain barrier and interact with the brain presents a significant scientific challenge," said Dr. Thomas Neumann, CEO of Nortis and Principal Investigator on this project.?"More predictive preclinical models based on human tissue are urgently needed to reduce costs and minimize clinical trial failures. This grant will help us develop new in-vitro alternatives to traditional pharmaceutical drug development testing on laboratory animals. " 

About Nortis  
Nortis is a privately held Organs-on-Chip company that is revolutionizing traditional drug development and discovery processes. The company is a leader in the 70% CAGR Organs-on-Chip market, projected by Research and Markets to reach $1.3B by 2022. Nortis has more than 30 customers using its systems, including biopharma leaders and top academic centers like the University of Washington, Fred Hutchinson Cancer Research Center and Massachusetts Institute of Technology (MIT). For more information about Nortis visit www.nortisbio.com.

About ParVivo 
The ParVivo system provides organizations with the ability to accurately investigate living 3D models of human organs and accelerate the discovery and introduction of new therapies into the market. The in-vitro alternative to today's laboratory animal testing models accurately replicates the biological structure and function of living human organs with the aim of reducing clinical trial failures. Organ models currently under development by scientists and application developers using ParVivo include applications for kidney, brain, heart, liver, immune system, blood vessels, cancer and personalized medicine.

Nortis, Inc. 
Kevin M. Banks, Ph.D. 
Vice President Sales and Marketing 
(425) 443-0428 
172741@email4pr.com

View original content with multimedia:http://www.prnewswire.com/news-releases/nortis-awarded-688k-nih-phase-ii-sbir-fast-track-grant-to-develop-living-model-of-human-blood-brain-barrier-300506430.html


'/>"/>
SOURCE Nortis
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. CerSci Therapeutics Awarded Phase II SBIR Grant from the National Institute on Drug Abuse of the National Institutes of Health
2. Vivify Health Awarded Patent for Extending EMRs with Digital Health
3. CerSci Therapeutics Awarded $225K Phase I NIH SBIR Grant for the Treatment of Neuropathic Pain
4. Merge Awarded 2017 Best in KLAS Designations; Hemodynamic Solution Named KLAS Category Leader for Sixth Consecutive Year
5. Getinge Group Awarded Three-Year Contract from Vizient, Inc. for Extensive Portfolio of Peripheral Vascular Products
6. Profusa, Inc. and North Carolina State Universitys ASSIST Center Awarded $1.5M NIH Grant to Co-Develop Ultrathin, Wearable, Wireless, Oxygen Monitor for Patients with Peripheral Artery Disease
7. MeiraGTx Awarded Target ALS Grant For Its NMD-Based Therapy for ALS
8. Personal Genome Diagnostics Awarded National Cancer Institute Contract to Develop Novel Diagnostic for Immuno-Oncology Drugs
9. This Years Crafoord Prize is Awarded for Fundamental Discoveries in Immune Regulation
10. CE Marking Awarded to Parkinsons Digital Health Technology
11. Kewaunee Scientific Awarded $8.4 Million Contract for CUNY Project
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2017)... reviews on the independent review site Consumer Affairs have ... hearing aids, ranking it higher than Miracle Ear ™, Beltone™, ... ... Aids ... that provides high performance, state-of-the-art, German-engineered hearing aids directly to consumers ...
(Date:9/9/2017)... YORK , Sept. 8, 2017 Dealmed ... largest independent supplier of medical equipment, supplies, drugs, vaccines, ... it has entered into an agreement to acquire Vantage ... equipment based in Holtsville, New York ... specializes in supplying new and emerging medical practices, will ...
(Date:9/7/2017)... RANCHO MIRAGE, Calif. , Sept. 7, 2017  For nearly two ... and service in the Assisted Reproduction Insurance industry. Today, New Life Agency ... expensive fertility medications. ... http://pharmacarecard.com/ (PRNewsfoto/PharmaCareCard) ... ...
Breaking Medicine Technology:
(Date:9/19/2017)... ... September 19, 2017 , ... ... Corporation recently unveiled the MirixaPro 6.0 platform. As the industry’s leading Medication ... services are delivered. Based on industry research and market feedback, the latest ...
(Date:9/19/2017)... ... 19, 2017 , ... Back Pain Centers of America ... pain with a reputable physician in their area, announces the addition of Allegion ... Nevada Spine Clinic was founded by board-certified spine surgeon, Jaswinder Grover, M.D. ...
(Date:9/19/2017)... , ... September 19, 2017 , ... The ISO 9001 ... help businesses and organizations become more efficient and improve customer satisfaction. ISO 9001:2015 was ... their own QMS, with a deadline of September 2018. , As described ...
(Date:9/19/2017)... (PRWEB) , ... September 19, ... ... MS, DACVIM, a board-certified veterinary oncologist, has agreed to serve as strategic ... SNOAW). Dr. Tripp is founder of the Bridge Animal Referral Center ...
(Date:9/19/2017)... ... September 19, 2017 , ... Ron Norman, CEO of Team Decades, ... of making a distinct rather than generic impression in the job market if one ... a stack of resumes knows that the first impression they give off is not ...
Breaking Medicine News(10 mins):